Special Report | Markets in Turmoil: Gilead Latest
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
30 Apr 202044min
Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation
A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within tw...
29 Apr 202026min
Special Report | Markets in Turmoil: Reopening Malls
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
29 Apr 202045min
Treasury Secretary Steven Mnuchin & Brown University President Christina Paxton
The Paycheck Protection Program resumed this week with a fresh infusion of $310 billion for America’s small businesses. Treasury Secretary Steven Mnuchin addresses flaws in the relief package, includi...
28 Apr 202024min
Special Report | Markets in Turmoil: Expanding Testing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
28 Apr 202045min
NJ Governor: ‘Everyone’s got a plan until you’re punched in the face’
New York and New Jersey have the highest number of coronavirus cases and related deaths in the U.S. As leaders in other states plan to reopen businesses amid the pandemic, New Jersey Governor Phil Mur...
27 Apr 202034min
Special Report | The Path Forward: Your Business
In this CNBC special report, Shark Tank's Daymond John and individual business owners discuss challenges and struggles in the midst of the coronavirus crisis. Hosted by Simplecast, an AdsWizz company....
25 Apr 202044min
Do Not Drink the Bleach; Another Round of Relief; Drafting from Home
An accidental post on the WHO website revealed that Gilead’s coronavirus treatment Remdesivir may fall short of the world’s high expectations. Former FDA Commissioner Dr. Scott Gottlieb explains the v...
24 Apr 202031min
